Qiagen NV (Qiagen NV) EV-to-Revenue : 4.96 (As of Apr. 24, 2024)

View and export this data going back to 1996. Start your Free Trial

What is Qiagen NV EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Qiagen NV's enterprise value is $9,747 Mil. Qiagen NV's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $1,965 Mil. Therefore, Qiagen NV's EV-to-Revenue for today is 4.96.

The historical rank and industry rank for Qiagen NV's EV-to-Revenue or its related term are showing as below:

QGEN' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.88 Med: 5.54 Max: 8.29
Current: 4.96

During the past 13 years, the highest EV-to-Revenue of Qiagen NV was 8.29. The lowest was 3.88. And the median was 5.54.

QGEN's EV-to-Revenue is ranked worse than
65.64% of 227 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.02 vs QGEN: 4.96

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-24), Qiagen NV's stock price is $41.52. Qiagen NV's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $8.81. Therefore, Qiagen NV's PS Ratio for today is 4.71.

Qiagen NV EV-to-Revenue Historical Data

The historical data trend for Qiagen NV's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV EV-to-Revenue Chart

Qiagen NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

5.68

7.10

6.00

5.52

5.28

Qiagen NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															5.52	5.54	5.48	4.97	5.28

Competitive Comparison of Qiagen NV's EV-to-Revenue

For the Diagnostics & Research subindustry, Qiagen NV's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qiagen NV's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Qiagen NV's EV-to-Revenue falls into.

Qiagen NV EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Qiagen NV's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	9746.909	/	1965.311
	=	4.96

Qiagen NV's current Enterprise Value is $9,747 Mil.
Qiagen NV's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,965 Mil.

Qiagen NV (NYSE:QGEN) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Qiagen NV's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	41.52	/	8.809
	=	4.71

Qiagen NV's share price for today is $41.52.
Qiagen NV's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.81.

Qiagen NV EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Qiagen NV's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Qiagen NV (Qiagen NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (NYSE:QGEN) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

1QGEN:Italy QIAd:UK 0RLT:UK QIA:Germany QIA:Germany QIA:Germany QIA:Germany QGEN:Austria

Address

Hulsterweg 82, Venlo, LI, NLD, 5912 PL

Website

https://www.qiagen.com

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).

Executives